Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP465943.RALlR8jnDf7c7UNQ7wjiQ_7XpFyq5Cz3lR7V3ALPz-tBU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP465943.RALlR8jnDf7c7UNQ7wjiQ_7XpFyq5Cz3lR7V3ALPz-tBU130_assertion type Assertion NP465943.RALlR8jnDf7c7UNQ7wjiQ_7XpFyq5Cz3lR7V3ALPz-tBU130_head.
- NP465943.RALlR8jnDf7c7UNQ7wjiQ_7XpFyq5Cz3lR7V3ALPz-tBU130_assertion description "[RAB25 mRNA levels were selectively increased in stage III and IV serous epithelial ovarian cancers compared to other genes within the amplified region, implicating RAB25 as a driving event in the development of the amplicon.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP465943.RALlR8jnDf7c7UNQ7wjiQ_7XpFyq5Cz3lR7V3ALPz-tBU130_provenance.
- NP465943.RALlR8jnDf7c7UNQ7wjiQ_7XpFyq5Cz3lR7V3ALPz-tBU130_assertion evidence source_evidence_literature NP465943.RALlR8jnDf7c7UNQ7wjiQ_7XpFyq5Cz3lR7V3ALPz-tBU130_provenance.
- NP465943.RALlR8jnDf7c7UNQ7wjiQ_7XpFyq5Cz3lR7V3ALPz-tBU130_assertion SIO_000772 15502842 NP465943.RALlR8jnDf7c7UNQ7wjiQ_7XpFyq5Cz3lR7V3ALPz-tBU130_provenance.
- NP465943.RALlR8jnDf7c7UNQ7wjiQ_7XpFyq5Cz3lR7V3ALPz-tBU130_assertion wasDerivedFrom befree-2016 NP465943.RALlR8jnDf7c7UNQ7wjiQ_7XpFyq5Cz3lR7V3ALPz-tBU130_provenance.
- NP465943.RALlR8jnDf7c7UNQ7wjiQ_7XpFyq5Cz3lR7V3ALPz-tBU130_assertion wasGeneratedBy ECO_0000203 NP465943.RALlR8jnDf7c7UNQ7wjiQ_7XpFyq5Cz3lR7V3ALPz-tBU130_provenance.